Rockwell Medical Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.4% | -5.3% | -29.3% | -10.6% | -15.7% | +75.4% | -37.5% | -4.0% | +11.9% | +13.5% | -3.5% | |
| – | -10.6% | -7.2% | -37.8% | -4.1% | -21.3% | +88.4% | -49.2% | +0.1% | -18.5% | +28.7% | +3.1% | |
| – | -52.6% | -44.9% | -51.1% | +170.2% | -48.1% | +312.7% | -72.7% | -23.9% | -11.1% | +74.4% | -31.6% | |
| – | -17.6% | -18.0% | -42.9% | +1.4% | -22.3% | +125.3% | -61.8% | -4.2% | -49.1% | +97.5% | +15.7% | |
| – | +12.9% | +26.7% | -0.6% | +15.7% | -42.8% | -0.8% | +41.8% | +5.9% | +74.2% | -23.9% | -1.8% | |
| – | +100.8% | +54.2% | -37.1% | -47.1% | -9.7% | +7.3% | +4.2% | +42.6% | +1.0% | -1.6% | -40.7% | |
| – | +10.0% | +95.4% | +165.2% | -49.9% | -32.8% | +93.2% | +84.1% | -15.8% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -50.2% | -97.4% | -8.1% | -8.6% | -9.8% | – | – | – | – | -5.1% | -5.4% | |
| – | -13.0% | +18.4% | -14.3% | -2.3% | -5.1% | +81.6% | +5.6% | -29.3% | -5.1% | -13.8% | -24.3% | |
| – | -17.5% | +25.4% | -9.9% | +44.4% | -6.3% | +3.4% | +63.9% | -15.6% | -6.0% | -15.3% | -32.0% | |
| – | – | – | – | – | -59.3% | -48.3% | +741.6% | -57.9% | -47.3% | +11.5% | -22.4% | |
| – | -24.5% | +46.6% | -27.9% | +6.4% | -32.8% | +37.7% | -10.0% | +8.4% | +11.4% | -36.5% | -30.3% | |
| – | – | – | – | – | – | – | -37.1% | -42.7% | +9.8% | +2.2% | +4.2% | |
| – | -9.3% | -15.0% | -37.8% | -17.1% | -25.5% | +68.2% | -92.6% | +456.4% | +50.9% | +53.1% | +13.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.1% | +2.1% | +0.1% | +3.9% | +15.3% | +24.1% | +24.0% | +15.7% | +136.4% | +33.2% | +15.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.